Specialty Pharmacy

Increased salt intake may magnify the risk of relapses in patients with multiple sclerosis.

Progress made on new Ebola drugs as US government pledges resources to West Africa.

Scientists discover how to stop cells from attacking healthy tissue.

New treatment option for treatment of orthostatic dizziness.

A recent study published in the journal Hepatology indicates that as many as 11% of baby boomers had a positive test result for presence of anti-HCV antibodies.

FDA decision expected by early 2015.

A recent meta-analysis published in the journal Plos One indicates a potential link between breast cancer and use of a common blood pressure medication, but a closer look tells a different story.

Humanitarian organization says world leaders are failing to address epidemic.

Experimental vaccine could begin clinical trials in humans in early 2015.

Pembrolizumab is the first drug approved that blocks the PD-1 cellular pathway.

Study finds HIV suppression reduces hepatitis C viral replication over time.

John Musil, PharmD, chief executive officer and founder of Avella Specialty Pharmacy, discusses how the specialty pharmacy model is evolving.

Director of Centers for Disease Control and Prevention cautions that outbreak in West Africa is outpacing the response.

Experts at Johns Hopkins say ability to go off antiviral treatment for an extended period of time is a critical goal.

Elelyso offers pediatric patients with Type 1 Gaucher disease another treatment option.

National Institutes of Health and GlaxoSmithKline will conduct safety evaluations on collaborative treatment in human subjects starting this week.

New treatments drive growth forecast.

Thiopurines found to increase the risk of myeloid disorders.

Researchers seek to get ahead of potential future Ebola outbreaks.

Program offers patients choice and flexibility in how they access their specialty medications, while providing centralized, expert clinical support.

TIM-family proteins may be able to block a wide range of viral infections.

A protein found in nearly half of African Americans speeds removal of medication from the body.

Experimental drug results in 100% recovery in primates up to 5 days following infection.

Medicaid beneficiaries are more likely to be screened for 3 types of cancer in states where physicians receive higher payments for office visits, a study suggests.

Phase I study deems treatment safe and tolerable in humans.

Treatment co-developed by National Institutes of Health and GlaxoSmithKline gets fast-tracked as World Health Organization issues dire prediction.

Michael Nameth, RPh, MBA, chief executive officer of Aureus Health Services, discusses the evolving role of the mid-size specialty pharmacy.

Limitations in available staff and protective equipment put medical personnel at increased risk.